HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved survival from intracavitary photodynamic therapy of rat glioma.

Abstract
The effectiveness of intratumoral photoradiation in photodynamic therapy (PDT) using a polyporphyrin photosensitizer was studied in the RT-2 rat glioma model. One week after intracerebral implantation of RT-2 cells, experimental rats received a single i.p. injection of 2 mg/kg of Photofrin. After administration of the photosensitizer (48 h), the tumors were partially resected and the exposed cavity was irradiated with 15 J of laser light at a wavelength of 630 nm. Further treatment with a large craniectomy significantly enhanced rat survival. Control rats which received no photosensitizer but were treated with surgery, alone or in combination with laser irradiation, succumbed from early tumor recurrence. Photodynamic therapy without decompressive surgery resulted in hemorrhagic infarction of residual tumor and adjacent brain with focal cerebral edema which resulted in cerebral herniation and early death. Our results indicate that photodynamic therapy is effective in treating residual brain tumor but at the expense of brain tissue surrounding the tumor. Unless relieved, intracranial pressure from photodynamic therapy-associated cerebral edema in this animal model resulted in shortened survival.
AuthorsY Ji, D Walstad, J T Brown, S K Powers
JournalPhotochemistry and photobiology (Photochem Photobiol) Vol. 56 Issue 3 Pg. 385-90 (Sep 1992) ISSN: 0031-8655 [Print] United States
PMID1438574 (Publication Type: Journal Article)
Chemical References
  • Radiation-Sensitizing Agents
  • Hematoporphyrin Derivative
Topics
  • Animals
  • Brain Neoplasms (diagnosis, drug therapy, pathology, surgery)
  • Cell Line
  • Glioma (diagnosis, drug therapy, pathology, surgery)
  • Hematoporphyrin Derivative (therapeutic use)
  • Light
  • Magnetic Resonance Imaging
  • Male
  • Photochemotherapy
  • Radiation-Sensitizing Agents (therapeutic use)
  • Rats
  • Rats, Wistar

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: